PharmiWeb.com - Global Pharma News & Resources

Company Directory - Research & Development

IDEAYA is a synthetic lethality-focused precision medicine oncology company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go.
We combine the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry.
Invizius is a Scotland based start-up founded by Dr Andy Herbert and Richard Boyd, which aims to reduce the damaging inflammatory effects of dialysis and cardiopulmonary bypass on patients through its patented H-Guard® Priming Solution.
Jubilant Biosys is a subsidiary of Jubilant Life Sciences, servicing as a contract research, development, and manufacturing organization (CRDMO), and has a presence in India and the United States.
Kemio Solutions is a reliable Contract Research and Contract Manufacturing Organization in India, offering single-point access to drug discovery, custom chemical synthesis and pharmaceutical technologies to global pharma and biotech companies.
Kwizda Group has set its sights on finding forward-looking solutions – be it in the development of pharmaceutical drugs, in the sale and distribution thereof or in the dispensing of medicines to patients.
Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.
LifeTein, the custom peptide synthesis service company, has developed proprietary PeptideSyn technology. This technology provides a platform for continuous peptide synthesis using microwave technology at a competitive price.